Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children
- 1 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (3) , 509-516
- https://doi.org/10.1097/00002030-200402200-00018
Abstract
To identify early life predictors of clinical progression before and beyond age 1 year. Prospective follow-up of 161 vertically HIV infected children in the ongoing European Collaborative Study provided data from birth over 16 years. Kaplan-Meier and Cox regression procedures were used to assess the predictive value of first available laboratory and clinical markers for progression defined as serious disease or death. We investigate gender and race effects on associations and the optimal threshold for longitudinal CD4+ percentage measurements after age 6 months for predicting disease progression. Earliest (during the first 6 months) measurements of CD4+ percentage below 20% [three-fold increased risk (P = 0.041)] and absolute lymphocytes (AL) (reduction of risk of three-quarters for a one log increase (P =0.014)) were independently associated with overall and rapid disease progression during the first year. Persistent lymphadenopathy (or hepatomegaly) in early life was also additionally associated with overall disease progression, and after age 1 year [greater than doubling of risk, (P = 0.040)], but not with rapid progression. Associations were not significantly dependent on gender or race. CD4+ percentage of 10% was the best prognostic cut-off. Early clinical markers are strongly predictive of disease progression after 1 year of age into adolescence. However, rapid progression is less straightforward to predict, probably due largely to early progression during the first few months in such individuals. The independently predictive value of AL measurements suggest they could be used alone in the management of children in resource-poor settings.Keywords
This publication has 20 references indexed in Scilit:
- Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy eraAIDS, 2004
- Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysisThe Lancet, 2003
- Are There Gender and Race Differences in Cellular Immunity Patterns Over Age in Infected and Uninfected Children Born to HIV-Infected Women?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys?AIDS, 2002
- HIV-infected pregnant women and vertical transmission in Europe since 1986AIDS, 2001
- Predictive Value of Quantitative Plasma HIV RNA and CD4+ Lymphocyte Count in HIV-Infected Infants and ChildrenPublished by American Medical Association (AMA) ,1998
- Disease patterns and survival after acquired immunodeficiency syndrome diagnosis in human immunodeficiency virus-infected childrenThe Pediatric Infectious Disease Journal, 1996
- Rapid Increases In Load Of Human Immunodeficiency Virus Correlate With Early Disease Progression and Loss of CD4 Cells in Vertically Infected InfantsThe Journal of Infectious Diseases, 1994
- Children born to women with HIV-1 infection: natural history and risk of transmissionThe Lancet, 1991
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982